Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Work | 1 | 2014 | 12 | 0.460 |
Why?
|
| Faculty, Medical | 1 | 2014 | 281 | 0.360 |
Why?
|
| Family | 1 | 2014 | 588 | 0.360 |
Why?
|
| Sodium | 1 | 2012 | 307 | 0.350 |
Why?
|
| Creatinine | 1 | 2012 | 423 | 0.340 |
Why?
|
| Chest Pain | 1 | 2011 | 133 | 0.330 |
Why?
|
| Cystic Fibrosis | 2 | 2021 | 264 | 0.290 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2003 | 217 | 0.230 |
Why?
|
| Pediatrics | 1 | 2014 | 1217 | 0.230 |
Why?
|
| Actinin | 1 | 2003 | 7 | 0.210 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2003 | 11 | 0.210 |
Why?
|
| Muscle Proteins | 2 | 2003 | 423 | 0.210 |
Why?
|
| Myoblasts | 1 | 2003 | 36 | 0.210 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2021 | 48 | 0.180 |
Why?
|
| Chloride Channel Agonists | 1 | 2020 | 4 | 0.180 |
Why?
|
| Aminophenols | 1 | 2020 | 8 | 0.170 |
Why?
|
| Benzodioxoles | 1 | 2020 | 9 | 0.170 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2020 | 47 | 0.170 |
Why?
|
| Quinolones | 1 | 2020 | 56 | 0.170 |
Why?
|
| Aminopyridines | 1 | 2020 | 60 | 0.170 |
Why?
|
| Myocardium | 1 | 2003 | 1046 | 0.140 |
Why?
|
| Suburban Health | 1 | 2012 | 2 | 0.100 |
Why?
|
| Endometrium | 1 | 2005 | 287 | 0.100 |
Why?
|
| Sodium, Dietary | 1 | 2012 | 37 | 0.100 |
Why?
|
| Endometriosis | 1 | 2005 | 184 | 0.100 |
Why?
|
| New York | 1 | 2012 | 73 | 0.100 |
Why?
|
| Diet Surveys | 1 | 2012 | 103 | 0.100 |
Why?
|
| Age Distribution | 1 | 2012 | 444 | 0.090 |
Why?
|
| Reference Values | 1 | 2012 | 742 | 0.090 |
Why?
|
| Angiography | 1 | 2011 | 215 | 0.080 |
Why?
|
| Radiography, Thoracic | 1 | 2011 | 152 | 0.080 |
Why?
|
| Linear Models | 1 | 2012 | 722 | 0.080 |
Why?
|
| Echocardiography | 2 | 2011 | 1124 | 0.070 |
Why?
|
| LIM Domain Proteins | 2 | 2003 | 62 | 0.070 |
Why?
|
| Protein Binding | 2 | 2005 | 1836 | 0.060 |
Why?
|
| Diet | 1 | 2012 | 1196 | 0.060 |
Why?
|
| Humans | 9 | 2022 | 133932 | 0.060 |
Why?
|
| Mutation | 3 | 2020 | 6297 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2005 | 3167 | 0.050 |
Why?
|
| Child | 4 | 2022 | 25739 | 0.050 |
Why?
|
| Sarcomeres | 1 | 2003 | 34 | 0.050 |
Why?
|
| Dystrophin | 1 | 2003 | 44 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 3739 | 0.050 |
Why?
|
| Asthma | 1 | 2011 | 812 | 0.050 |
Why?
|
| Lung | 1 | 2011 | 1557 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2196 | 0.050 |
Why?
|
| Biomarkers | 1 | 2012 | 3423 | 0.050 |
Why?
|
| Clofazimine | 1 | 2021 | 7 | 0.050 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2021 | 26 | 0.050 |
Why?
|
| Actins | 1 | 2003 | 352 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2003 | 688 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2003 | 381 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 584 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2020 | 224 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2020 | 283 | 0.040 |
Why?
|
| Obesity | 1 | 2011 | 2413 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2012 | 8592 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2003 | 799 | 0.040 |
Why?
|
| Base Sequence | 1 | 2003 | 3171 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 739 | 0.040 |
Why?
|
| Homozygote | 1 | 2020 | 560 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2003 | 1066 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3970 | 0.040 |
Why?
|
| Infant | 1 | 2012 | 13161 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1495 | 0.030 |
Why?
|
| Disease Progression | 1 | 2022 | 2239 | 0.030 |
Why?
|
| Culture Techniques | 1 | 2005 | 82 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2005 | 363 | 0.030 |
Why?
|
| Epithelium | 1 | 2005 | 370 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2005 | 313 | 0.030 |
Why?
|
| Adolescent | 2 | 2022 | 20536 | 0.030 |
Why?
|
| Male | 2 | 2020 | 65882 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 3054 | 0.020 |
Why?
|
| Mice | 1 | 2003 | 18911 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2003 | 270 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 364 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2003 | 354 | 0.010 |
Why?
|
| Animals | 1 | 2003 | 36398 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 1089 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 1134 | 0.010 |
Why?
|
| Female | 2 | 2020 | 71659 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 29394 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 619 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1761 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 31946 | 0.010 |
Why?
|